DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Anti-Infective AgentsAnti-Infective Agents
  5. /HBVHBV
  6. /FirzacorvirFirzacorvir
Chemical structure of CAS 2243747-96-6

Firzacorvir

CAS No.2243747-96-6
MDL No.N/A
MFC18H18ClFN6O3S2
MW485.00
InChI KeyXVKTYEAUJPZPDZ-HIFRSBDPSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2243747-96-6
Product NameFirzacorvir
Heavy Atom Count31Rotatable Bond Count4
Atom Stereo Count2Bond Stereo Count0
HBA7HBD2
TPSA109.220 ŲCharge0
Exact Mass484.05544Complexity1244.66
pKa9.247XLogP2.554

Related Articles

Studies related to this compound and its mechanism of action

Preclinical characterization of ABI-H2158, an HBV core inhibitor with dual mechanisms of action.

Antiviral research • Vol. 209 • 2023
PMID: 36509208DOI: 10.1016/j.antiviral.2022.105485

Hepatitis B core protein as a therapeutic target.

Expert opinion on therapeutic targets • Vol. 21, Issue 12 • 2017
PMID: 29065733DOI: 10.1080/14728222.2017.1397134

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact